MICAL2 and familial pancreatic carcinoma: Future research should be directed at gaining a better understanding of the complex mechanism underlying the role played by MICAL2 in promoting the interaction between CAFs and immune cells, as this may enable effective targeted therapy and immunotherapy to be developed against pancreatic cancer.